It could support the hypothesis of other investigators who suggest the lesser importance of LOH in RASSF1A inactivation in NSCLC tumorigenesis and the prevalence of epigenetic modifications [33, 34]. The gene discussed is RASSF1; the disease is non-small cell lung carcinoma.